COMMUNIQUÉS West-GlobeNewswire
-
Kriya Announces Presentations at ASGCT 2026 Highlighting Advances Across Gene Therapy Platform
30/04/2026 -
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
30/04/2026 -
Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026
30/04/2026 -
Vicarious Surgical Reports First Quarter 2026 Financial Results
30/04/2026 -
Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment
30/04/2026 -
Spectral AI Wins Small Business Innovator Award at Inaugural Texas Innovation Conference
30/04/2026 -
Willow Glow Wellness Spa Clinics Announces Advanced LED Facelift Protocol, Attracting Silicon Valley Clients for Non-Surgical Skin Rejuvenation
30/04/2026 -
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
30/04/2026 -
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange
30/04/2026 -
VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery
30/04/2026 -
Centre for Neuro Skills CEO David Harrington Joins Brain to Brain Podcast to Discuss the Science of Recovery, Advocacy for Brain Injury Care and Why It Is Never Too Late
30/04/2026 -
New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms
30/04/2026 -
Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT)
30/04/2026 -
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
30/04/2026 -
TOMI Environmental Solutions Signs Letter of Intent for a Merger with Carbonium Core, Inc., a U.S.-Based Producer of Nuclear-Grade Graphite for Advanced Reactors and Infrastructure Demands of AI Data Centers
30/04/2026 -
Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
30/04/2026 -
TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business Update
30/04/2026 -
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
30/04/2026 -
BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer
30/04/2026
Pages